Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report

AnticonvulsantsExample report

Brivaracetam

Briviact

Use with caution

Your body breaks down this drug more slowly, so more of it builds up. This can raise the risk of side effects.

The genes behind this label

The guidelines read one gene for brivaracetam. Each card shows the two copies this person inherited and what they mean.

Intermediate metabolizer

One copy works and one doesn't.

Handles several SSRIs, acid reducers such as omeprazole, and the blood thinner clopidogrel.

This result changes the label.

What each guideline says about your result.

CYP2C19Intermediate metabolizer

FDA drug label

In plain words: Your body breaks down this drug more slowly, so more of it builds up. This can raise the risk of side effects.
What it means: Results in higher systemic concentrations and higher adverse reaction risk.
What the label suggests: No specific dosing change for intermediate metabolizers. Refer to FDA labeling.

Brivaracetam (Briviact) is an antiseizure medicine for partial-onset (focal) seizures in people 1 month and older.

Used for: Partial-onset seizures in people 1 month and older, alone or with other antiseizure medicines

Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.